Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International, Cross Sectional, Non-interventional, Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea

NCT01234168 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT01234168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01234168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International, Cross Sectional, Non-interventional, Study to Assess Neuroendocrine Tumour (NET) Patients Currently Treated by Somatuline Autogel for History of Carcinoid Syndrome Associated With Episodes of Diarrhea
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
October 31, 2010
Completion date
December 31, 2012
Enrollment
340 (actual)
Sites
57

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoid syndrome, neuroendocrine tumors